Pharmacovigilance of oral bisphosphonates: Adverse effects manifesting in the soft tissue of the oral cavity

Journal of Oral and Maxillofacial Surgery

Volumn 70, Issue 12, 2012, Pages 2793-2797

  Kharazmi, Mohammad ^a   Persson, Ulf ^b   Warfvinge, Gunnar ^c  

^a CENTRAL HOSPITAL   (Sweden)

^b MEDICAL PRODUCTS AGENCY   (Sweden)

^c MALMÖ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CLODRONIC ACID; ETIDRONIC ACID; IBANDRONIC ACID; RISEDRONIC ACID;

ADULT; AGED; ARTICLE; BONE NECROSIS; BURNING SENSATION; CLINICAL ARTICLE; DRUG SURVEILLANCE PROGRAM; DRUG USE; DRUG WITHDRAWAL; FEMALE; GINGIVA BLEEDING; GINGIVITIS; HUMAN; MALE; MOUTH CAVITY; MOUTH MUCOSA; MOUTH PAIN; MOUTH ULCER; MUCOSA; ORAL BLEEDING; ORAL BLISTER; ORAL MUCOSAL DISEASE; STOMATITIS; TONGUE SWELLING; TONGUE ULCER; TREATMENT DURATION;

ADMINISTRATION, ORAL; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; ALENDRONATE; BLISTER; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; DRUG MONITORING; ETIDRONIC ACID; FEMALE; GINGIVAL DISEASES; HUMANS; MALE; MIDDLE AGED; MOUTH DISEASES; ORAL ULCER; PHARMACOVIGILANCE; SWEDEN; TIME FACTORS; TONGUE DISEASES;

EID: 84868696685     PISSN: 02782391     EISSN: 15315053     Source Type: Journal    
DOI: 10.1016/j.joms.2012.01.025     Document Type: Article

References (22)

1. R.E. Marx Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic J Oral Maxillofac Surg 61 2003 1115
2. M. Kharazmi, K. Sjöqvist, G. Warfvinge Oral Ulcers, a Little Known Adverse Effect of Alendronate: Review of the Literature J Oral Maxillofac Surg 70 4 2012 Apr [Epub ahead of print]
3. F. Cardona Tortajada, E. Sainz Gómez, J. Figuerido Garmendia, A. Lirón de Robles Adsuar Úlcera oral crónica por ingestion de alendronato Aten Primaria 40 2008 430
4. M.A. Gonzalez-Moles, J.V. Bagan-Sebastian Alendronate-related oral mucosa ulcerations J Oral Pathol Med 29 2000 514
5. M. Kharazmi, K. Sjöqvist, M. Rizk Oral ulcer associated with alendronate: A case report Oral Surg Oral Med Oral Pathol Oral Radiol Endod 110 2010 e11
6. F.L. Lanza, R.H. Hunt, A.B. Thomson Endoscopic comparison of esophageal and gastroduodenal effects of risedronate and alendronate in postmenopausal women Gastroenterology 119 2000 631
7. K. Kanatsu, E. Aihara, M. Okayama Mucosal irritative and healing impairment action of risedronate in rat stomachs: Comparison with alendronate J Gastroenterol Hepatol 19 2004 512
8. R.E. Marx Clinical concerns of alendronate use J Oral Maxillofac Surg 66 2008 1322
9. A.A. Reszka, J. Halasy-Nagy, G.A. Rodan Nitrogen-bisphosphonates block retinoblastoma phosphorylation and cell growth by inhibiting the cholesterol biosynthetic pathway in a keratinocyte model for esophageal irritation Mol Pharmacol 59 2001 193
10. M.J. Rogers New insights into the molecular mechanisms of action of bisphosphonates Curr Pharm Des 9 2003 2643
11. R. Landesberg, M. Cozin, S. Cremers Inhibition of oral mucosal cell wound healing by bisphosphonates J Oral Maxillofac Surg 66 2008 839
12. V.F.P. Correia, C.L. Caldeira, M.M. Marques Cytotoxicity evaluation of sodium alendronate on cultured human periodontal ligament fibroblasts Dent Traumatol 22 2006 312
13. J. Wood, K. Bonjean, S. Ruetz Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid J Pharmacol Exp Ther 302 2002 1055
14. G. Yin, Y. Bai, E. Luo Angiogenic suppression of osteoclasts may play a role in developing bisphosphonate-related osteonecrosis of the jaw Med Hypotheses 76 2011 347
15. J.L. Wallace, M. Dicay, W. McKnight N-bisphosphonates cause gastric epithelial injury independent of effects on the microcirculation Aliment Pharmacol Ther 13 1999 1675
16. I.R. Reid, M.J. Bolland, A.B. Grey Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? Bone 41 2007 318
17. P.C. de Groen, D.F. Lubbe, L.J. Hirsch Esophagitis associated with the use of alendronate N Engl J Med 335 1996 1016
18. B.M. Kuehn Prolonged bisphosphonate use linked to rare fractures, esophageal cancer JAMA 304 2010 2114
19. Adverse Drug Reactions Committee A gut feeling for alendronate Aust Adv Drug React Bull 18 1999 11
20. P. Rubegni, M. Fimiani Images in clinical medicine Bisphosphonate- associated contact stomatitis N Engl J Med 355 2006 e25
21. W. Aleid, A. Sidebottom Oral mucosal irritation with incorrect use of alendronate Br J Oral Maxillofac Surg 47 2009 170
22. D.M. Black, P.D. Delmas, R. Eastell Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis N Engl J Med 356 2007 1809